News

GJE act in all (100%) decided UKIPO patent revocation actions in 2016

Statistics show that GJE has unparalleled experience with the firm acting in all decided revocation actions at the UK IPO in 2016! [1] Before we get too carried away with this hyperbole, we must be frank … there were only three — with GJE acting as claimant and defendant in...

Read more

Peter Finnie and Rowena Price recognised by Chambers & Partners

Peter Finnie and Rowena Price have been recognised as leaders in their fields by the 2018 UK Chambers & Partners, having been ranked in ‘Band 1’ for patents and trade marks respectively. Less than 15 attorneys were selected across the UK for each category and we are delighted Peter and Rowena...

Read more

GJE recognised by The Legal 500

We are delighted to be recognised by The Legal 500 as a leading firm in the 2017 rankings. The Legal 500 provide a comprehensive worldwide review of the best and most recommended law firms and attorneys. The rankings are based on the practice area teams who are providing the most cutting edge...

Read more

Changes for UK registered design owners up to the mark

It is important that UK registered design owners mark their associated products in order to inform third parties of their registered design rights. Not only does this deter would-be infringers, but also helps to prevent “innocent infringement”. Under the UK Registered Designs Act, damages will not be awarded in infringement...

Read more

GJE’s oppositions team successfully argue for revocation of patent covering cancer treatment drug

Eisai Lenvima patent revoked by the EPO. On 26th September 2017, Arnie Clarke was representing one of two opponents to successfully seek revocation of EP2036557 at the European Patent Office (EPO). The EPO revoked the patent on the basis that the claims lacked an inventive step. The parent concerned Lenvima, known chemically...

Read more